Concepedia

Tesia Bobrowski

TB

8

Publications

317

Citations

8

H-Index

2020

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

In The Meantime Men’s Group

Research Triangle Park Foundation

National Institute of Environmental Health Sciences

National Center for Advancing Translational Sciences

Tesia Bobrowski is an author at University of North Carolina at Chapel Hill specializing in medicine, drug discovery, and biostatistics.

ORCID

Top concepts

Publications per year

2020–2025

8

Publications

8

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Tesia Bobrowski, Lu Chen, Richard T. Eastman et al. · Molecular Therapy · 2020 · 121 citations · Full text

QSAR Modeling of SARS‐CoV M <sup>pro</sup> Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2

Vinícius M. Alves, Tesia Bobrowski, Cleber C. Melo‐Filho et al. · Molecular Informatics · 2020 · 83 citations

Conserved coronavirus proteins as targets of broad-spectrum antivirals

Cleber C. Melo‐Filho, Tesia Bobrowski, Holli‐Joi Martin et al. · Antiviral Research · 2022 · 37 citations · Full text

, , +3

COVID-KOP: integrating emerging COVID-19 data with the ROBOKOP database

Daniel Korn, Tesia Bobrowski, Michael Li et al. · Bioinformatics · 2020 · 21 citations · Full text

Allosteric Binders of ACE2 Are Promising Anti-SARS-CoV-2 Agents

Joshua E. Hochuli, Sankalp Jain, Cleber C. Melo‐Filho et al. · ACS Pharmacology & Translational Science · 2022 · 21 citations · Full text

Rows per page

1–5 of 8